Genesis Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Genesis Biotechnologies
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmendra Patel and Rajesh Chourasia serve as directors at the Company.
- CIN/LLPIN
U02412MP1996PTC010643
- Company No.
010643
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationJablapur M.P., Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genesis Biotechnologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Patel  | Managing Director | 26-Jun-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Chourasia | Director | 17-Jul-2006 | Current |
Financial Performance and Corporate Structure Insights of Genesis Biotechnologies.
Genesis Biotechnologies Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genesis Biotechnologies?
In 2017, Genesis Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenhouse Agro-Products Pvt Ltd
Active 29 years 6 monthsDharmendra Patel and Rajesh Chourasia are mutual person
White Jade Minerals And Mining Private Limited
Active 3 years 20 daysDharmendra Patel is a mutual person
White Pyramid Mines And Minerals Private Limited
Active 2 years 11 monthsDharmendra Patel and Rajesh Chourasia are mutual person
Bandhavgarh Meadows Lodges Private Limited
Active 13 years 24 daysDharmendra Patel and Rajesh Chourasia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genesis Biotechnologies?
Unlock and access historical data on people associated with Genesis Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genesis Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesis Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
